Free Flow Medical Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
67
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.38M
- Investors
-
2
Free Flow Medical General Information
Description
Developer of respiratory therapies designed to treat chronic obstructive pulmonary disease, lung cancer, and asthma. The company offers therapies for chronic bronchitis and emphysema, with products manufactured in the United States and distributed through direct sales and distributors across North America, Europe, and South America, enabling healthcare providers to treat a broad range of respiratory diseases.
Contact Information
Website
www.freeflowmedical.comCorporate Office
- 44380 South Grimmer Boulevard
- Fremont, CA 94538
- United States
Corporate Office
- 44380 South Grimmer Boulevard
- Fremont, CA 94538
- United States
Free Flow Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 05-Apr-2023 | $6.38M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 05-May-2020 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 28-Feb-2019 | $2.82M | $2.82M | Completed | Startup |
Free Flow Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | 2,770,808 | $0.000010 | $0.76 | $0.76 | 1x | $0.76 | 6.43% | |
| Series A | 7,621,977 | $0.000010 | $0.39 | $0.39 | 1x | $0.39 | 17.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Free Flow Medical Patents
Free Flow Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240285307-A1 | Devices, methods, and systems to treat chronic bronchitis | Pending | 10-Mar-2022 | ||
| AU-2022258731-A1 | Valved devices, treatments and methods to restore tissue elastic recoil | Pending | 16-Apr-2021 | ||
| EP-4322888-A1 | Valved devices, treatments and methods to restore tissue elastic recoil | Pending | 16-Apr-2021 | ||
| EP-4322888-A4 | Valved devices, treatments and methods to restore tissue elastic recoil | Pending | 16-Apr-2021 | ||
| US-12708515-B2 | Valved devices, treatments and methods to restore tissue elastic recoil | Active | 16-Apr-2021 | A61F2/2476 |
Free Flow Medical Signals
Free Flow Medical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bridge Investments (Pennsylvania) | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Free Flow Medical FAQs
-
When was Free Flow Medical founded?
Free Flow Medical was founded in 2017.
-
Where is Free Flow Medical headquartered?
Free Flow Medical is headquartered in Fremont, CA.
-
What is the size of Free Flow Medical?
Free Flow Medical has 67 total employees.
-
What industry is Free Flow Medical in?
Free Flow Medical’s primary industry is Therapeutic Devices.
-
Is Free Flow Medical a private or public company?
Free Flow Medical is a Private company.
-
What is the current valuation of Free Flow Medical?
The current valuation of Free Flow Medical is .
-
What is Free Flow Medical’s current revenue?
The current revenue for Free Flow Medical is .
-
How much funding has Free Flow Medical raised over time?
Free Flow Medical has raised $11.3M.
-
Who are Free Flow Medical’s investors?
Bridge Investments (Pennsylvania) and have invested in Free Flow Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process